Abstracts Archive - Page 276 of 1683 - ATC Abstracts

2021 American Transplant Congress
Quantification of Multiple Isotypes of Anti-SARS-CoV-2 Antibodies in Kidney Transplant Recipients
J. S. Maltzman¹, L. Wang¹, P. Ahearn¹, T. Yalamarti¹, M. Menon², Y. Azzi³, M. Melcher¹, M. Fernandez-Vina¹, R. Bray⁴, H. Gebel⁴, E. Woodle⁵, E. Akalin³, A. Girnita¹, P. Cravedi²
¹Stanford University, Palo Alto, CA, ²Icahn School of Medicine, NYC, NY, ³Einstein School of Medicine, NYC, NY, ⁴Emory University, Atlanta, GA, ⁵University of Cincinnati, Cincinnati, OH
*Purpose: Solid organ transplant recipients are at increased risk of severe outcomes with infection by SARS-CoV-2, the etiologic agent of COVID-19. Antibodies directed against the…
2021 American Transplant Congress
SPK Transplantation in HIV-positive Recipients
H. Resweber, k. nguyen, H. Curtis, J. Panichella, A. DI Carlo, S. Karhadkar
Temple University School of Medicine, Philadelphia, PA
*Purpose: With the advent of anti-retroviral therapy in the treatment of HIV, mortality in HIV-infected individuals has become less due to complications from viral infection…
2021 American Transplant Congress
Baseline Levels of Dd-cf Dna After Pancreas Transplantation: Using Dd-cfdna as an Indicator for Pancreas Rejection and Biopsy Avoidance
A. Yoo, I. Qian, A. Riedel, C. Cazac, A. Bartosic, J. S. Bromberg, J. Scalea
Department of Surgery, Division of Transplant, University of Maryland School of Medicine, Baltimore, MD
*Purpose: Donor-derived cell-free DNA (dd-cfDNA) testing, which has been previously validated for monitoring kidney transplant (KTx) rejection, may provide an alternative to pancreas biopsy that…
2021 American Transplant Congress
Kidney Transplant Biopsy Findings After Covid-19
E. Daniel¹, S. Kudose², D. J. Cohen¹, L. Ratner³, V. D'Agati², I. Batal²
¹Division of Nephrology, Columbia University Medical Center, NY, NY, ²Department of Pathology, Columbia University Medical Center, NY, NY, ³Department of Surgery, Columbia University Medical Center, NY, NY
*Purpose: COVID-19 has been reported as a cause of kidney injury and data from published native kidney biopsy results demonstrate a variety of causes. To…
2021 American Transplant Congress
Monoclonal Antibodies for Covid-19 in Patients with Solid Organ Transplant Recipients
L. Hasan¹, H. Hardgrave², T. Osborn³, R. Dare¹, L. Burdine⁴, E. Giorgakis⁴, J. Rico¹
¹Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, ²University of Arkansas for Medical Sciences, Little Rock, AR, ³Surgery, University of Arkansas for Medical Sciences, Little Rock, AR, ⁴Transplant surgery, University of Arkansas for Medical Sciences, Little Rock, AR
*Purpose: The FDA has issued Emergency Use Authorization (EUA) for monoclonal antibodies for the treatment of mild to moderate COVID-19 in patients at risk for…
2021 American Transplant Congress
Update on Pancreas Retransplantation- A Registry Analysis
A. Gruessner, J. Renz, S. Saggi, R. Gruessner
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: A successful pancreas transplant provides patients with brittle diabetes the opportunity of good long-term metabolic control. While initially more and more retransplants were performed,…
2021 American Transplant Congress
Enteric Conversion After Bladder-drained Kidney-pancreas Transplantation
S. Sivan, M. Ortigosa-Goggins, M. Patel, M. Morsi, L. Chen, J. Figueiro, G. Ciancio, G. Burke
Miami Transplant Institute, University of Miami Miller School of Medicine, Jackson Memorial Hospital, Miami, FL
*Purpose: In simultaneous kidney-pancreas transplantation (SPK), bladder (BD) and enteric (ED) are both options for pancreaticoduodenal exocrine drainage. While BD provides good early and long…
2021 American Transplant Congress
White, Older Men Are Less Affected by the Changes of the Covid-19 Pandemic
R. J. Berkowitz, A. Daud, S. Brietigam, T. S. Taylor, J. Carter, M. A. Callegari, B. Borja-Cacho, J. C. Caicedo, D. Simpson, D. P. Ladner
Surgery, Northwestern Medicine, Chicago, IL
*Purpose: This study explores quality of life and lifestyle changes due to the COVID-19 pandemic among pre- and post- liver (LT) and kidney (KT) transplant…
2021 American Transplant Congress
Psychosocial Outcomes 1-year Post Total Pancreatectomy and Autologous Islet Cell Transplant
J. Steel¹, A. Amin¹, M. Wijkstrom¹, A. Zureikat¹, E. Tillman¹, R. Jones¹, D. Yadav¹, A. Slivka¹, A. Phillips¹, M. Bellin², A. Carroll³, A. Humar¹
¹University of Pittsburgh, Pittsburgh, PA, ²University of Minnesota, Minneapolis, MN, ³University of Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: A paucity of research regarding the psychosocial outcomes after-total pancreatectomy and autologous islet cell transplantation exists. The aim of the study was to examine…
2021 American Transplant Congress
Donor Derived Cell-Free DNA (dd-cfDNA) in Pancreas Transplant Recipients
S. Riad¹, H. Sarumi², R. Kandaswamy³
¹Medicine, University of Minnesota, Minneapolis, MN, ²Surgery, University of Minnesota Physicians, Minneapolis, MN, ³Surgery, University of Minnesota, Minneapolis, MN
*Purpose: Data on the role of DD-cfDNA after pancreas transplantation is lacking. Herein we report on our center experience with DD-cfDNA in 10 unique SPK…